|
PURB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.246200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.980100E-03 |
| Normal-vs-Stage2 |
8.942000E-03 |
| Normal-vs-Stage3 |
1.819180E-04 |
| Normal-vs-Stage4 |
7.011000E-04 |
| Stage1-vs-Stage2 |
5.577600E-01 |
| Stage1-vs-Stage3 |
1.056610E-01 |
| Stage1-vs-Stage4 |
1.708760E-01 |
| Stage2-vs-Stage3 |
5.589600E-01 |
| Stage2-vs-Stage4 |
5.132800E-01 |
| Stage3-vs-Stage4 |
8.844200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.141920E-03 |
| Normal-vs-AfricanAmerican |
7.256600E-01 |
| Normal-vs-Asian |
3.660000E-03 |
| Caucasian-vs-AfricanAmerican |
6.325600E-02 |
| Caucasian-vs-Asian |
7.054200E-01 |
| AfricanAmerican-vs-Asian |
1.056010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.04209999999217E-05 |
| Normal-vs-Female |
3.155800E-03 |
| Male-vs-Female |
9.911900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.502400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.04920000000431E-05 |
| Normal-vs-Age(61-80Yrs) |
7.772100E-04 |
| Normal-vs-Age(81-100Yrs) |
9.126300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.033600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.808100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.253800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.817400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.068200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.697200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.743500E-03 |
| Classical-VS-Follicular |
1.617610E-02 |
| Classical-VS-Other |
2.750400E-01 |
| Classical-VS-Normal |
1.652160E-02 |
| Tall-VS-Follicular |
4.891200E-01 |
| Tall-VS-Other |
9.675000E-01 |
| Tall-VS-Normal |
1.632840E-04 |
| Follicular-VS-Other |
7.792600E-01 |
| Follicular-VS-Normal |
3.555400E-04 |
| Other-VS-Normal |
6.134200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.005430E-04 |
| Normal-vs-N1 |
3.843100E-03 |
| N0-vs-N1 |
9.301200E-01 |
|
|
